110 likes | 123 Vues
The purpose of the study is to gain a holistic view of the active plasma medicine projects implemented in several countries. The report contains the analysis of various such as recent trends, technological advancements, reimbursement scenario, and international level initiatives across the globe influencing the adoption of plasma medicine.
E N D
Plasma Medicine Market: Strategies and Implementation Table of Content Attribution: https://pixabay.com/photos/tire-rim-car-mechanic-114259/ Plasma Medicine Market March 2022 1 All rights reserved at BIS Research Inc.
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this Plasma Medicine Market document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.
Table of Content Scope of the Study ............................................................................. 9 1.Strategies and Implementation .................................................. 11 1.1 Industry Overview ............................................................................................ 12 1.1.1Plasma Medicine: Overview ....................................................................... 12 1.1.2Timeline: Evolution of the Plasma Medicine ............................................. 12 1.2 An Insight on Plasma Medicine ...................................................................... 13 1.3 Applications ..................................................................................................... 13 1.3.1Therapeutic Applications ............................................................................ 14 1.3.2Biological Decontamination ....................................................................... 15 1.4 Risk Estimation ................................................................................................ 16 1.5 Basic Cell Biology of Plasma-Supplied Wound Healing .............................. 17 1.6 Challenges and Perspectives of Plasma Medicine ....................................... 18 1.7 Strategies for Implementation of Plasma Medicine (by Region) ................. 19 1.7.1North America .............................................................................................. 19 1.7.1.1 U.S. .................................................................................................................... 19 1.7.1.1.1U.S. Medical Innovations ......................................................................................... 19 1.7.1.1.2Products Offered by the Company........................................................................... 20 1.7.1.1.3The Canady Cold Plasma Procedure ...................................................................... 22 1.7.2Europe .......................................................................................................... 22 1.7.2.1 Netherlands ....................................................................................................... 22 1.7.2.1.1Plasmacure .............................................................................................................. 22 1.7.2.1.2Product Offered by the Company ............................................................................ 22 Plasma Medicine Market 1.7.2.2 Germany ............................................................................................................ 24 1.7.2.2.1neoplas med GmbH ................................................................................................. 24 1.7.2.2.1.1Product Offered by the Company ..................................................................... 24 1.7.2.2.1.2Treatment of Chronic Wounds: Mode of Action of the kINPen MED ............... 26 1.7.2.2.2terraplasma medical GmbH ..................................................................................... 26 3 All rights reserved at BIS Research Inc.
1.7.2.2.2.1Product offered by the Company ...................................................................... 27 1.7.2.2.3coldplasmatech GmbH ............................................................................................. 28 1.7.2.2.3.1Product offered by the Company: ..................................................................... 28 1.7.2.2.3.2CPT Treatment ................................................................................................. 29 1.7.2.3 Georgia .............................................................................................................. 29 1.7.2.3.1Plasma Surgical ....................................................................................................... 29 1.7.2.3.1.1Product Offered by the Company ..................................................................... 29 1.8 SWOT Analysis of Plasma Medicine .............................................................. 31 1.8.1Strengths ...................................................................................................... 32 1.8.2Weaknesses ................................................................................................. 32 1.8.3Opportunities ............................................................................................... 33 1.8.4Threats ......................................................................................................... 33 1.9 The Making of Plasma Medicine ..................................................................... 33 1.9.1Europe .......................................................................................................... 33 1.9.1.1 Germany ............................................................................................................ 33 1.9.1.1.1Trends in German Innovation Policy ........................................................................ 33 1.9.1.1.2Plasma Medication is Becoming More Prominent Method of Treatment ................. 34 1.9.1.1.3Strategic and Organizational Dilemmas and Management Issues: Trust Formation, Strategy Implementation, and Stakeholder Management .................... 34 1.9.1.1.4Policy Implications ................................................................................................... 36 1.10Recent Plasma Therapy News and Information ............................................ 37 1.10.1As a Potential Treatment for Diabetic Foot Ulcers, Cold Plasma Ionised Gas Could Also Kill COVID-19 Virus Indoors .............................. 37 1.10.2Cold Plasma against the Coronavirus ....................................................... 38 1.10.3Immunotherapy for Melanoma Could Be Improved by Using a Cold Plasma Patch ............................................................................................... 38 Plasma Medicine Market 1.11Competitive Benchmarking ............................................................................ 40 1.11.1US Medical Innovations .............................................................................. 40 1.11.1.1 Company Overview ........................................................................................... 40 4 All rights reserved at BIS Research Inc.
1.11.1.2 Role of US Medical Innovations in the Plasma Medicine Market ...................... 40 1.11.1.3 SWOT Analysis .................................................................................................. 42 1.11.2Plasmacure .................................................................................................. 43 1.11.2.1 Company Overview ........................................................................................... 43 1.11.2.2 Role of Plasmacure in the Plasma Medicine Market ......................................... 43 1.11.2.3 SWOT Analysis .................................................................................................. 44 1.11.3neoplas med GmbH ..................................................................................... 45 1.11.3.1 Company Overview ........................................................................................... 45 1.11.3.2 Role of neoplas med GmbH in the Plasma Medicine Market ............................ 45 1.11.3.3 SWOT Analysis .................................................................................................. 46 1.11.4Plasma Surgical ........................................................................................... 47 1.11.4.1 Company Overview ........................................................................................... 47 1.11.4.2 Role of Plasma Surgical in the Plasma Medicine Market .................................. 47 1.11.4.3 SWOT Analysis .................................................................................................. 48 1.11.5Coldplasmatech GmbH ............................................................................... 49 1.11.5.1 Company Overview ........................................................................................... 49 1.11.5.2 Role of coldplasmatech GmbH in the Global Plasma Medicine Market ............ 49 1.11.5.3 SWOT Analysis .................................................................................................. 50 1.11.6terraplasma medical GmbH ........................................................................ 51 1.11.6.1 Company Overview ........................................................................................... 51 1.11.6.2 Role of terraplasma medical GmbH in the Plasma Medicine Market ................ 51 1.11.6.3 SWOT Analysis .................................................................................................. 52 Plasma Medicine Market 5 All rights reserved at BIS Research Inc.
List of Figures Figure 1:Plasma Medicine Market: Segmentation Figure 2:Fields of Biomedical Applications of Physical Plasma Figure 3:Important Turning Points in the Evolution of Low-Temperature Plasma Medicine Figure 4:Basic Concept of Plasma Supported Wound Healing Figure 5:Departments of the Company Figure 6:Estimated New Cancers Figure 7:Effective Components of Cold Plasma Figure 8:Research Areas of the Product Figure 9:SWOT Analysis of CAP Technology Figure 10:US Medical Innovations: Product Portfolio Figure 11:US Medical Innovations: SWOT Analysis Figure 12:Plasmacure: Product Portfolio Figure 13:Plasmacure: SWOT Analysis Figure 14:neoplas med GmbH: Product Portfolio Figure 15:neoplas med GmbH: SWOT Analysis Figure 16:Plasma Surgical: Product Portfolio Figure 17:Plasma Surgical: SWOT Analysis Figure 18:Coldplasmatech GmbH: Product Portfolio Figure 19:Coldplasmatech GmbH: SWOT Analysis Figure 20:terraplasma medical GmbH: Product Portfolio Figure 21:terraplasma medical GmbH: SWOT Analysis Plasma Medicine Market 6 All rights reserved at BIS Research Inc.
BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More Plasma Medicine Market Know More 7 All rights reserved at BIS Research Inc.
Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 Plasma Medicine Market 8 All rights reserved at BIS Research Inc.
BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Plasma Medicine Market Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com 9 All rights reserved at BIS Research Inc.